The Systemic Lupus International Collaborating Clinics (SLICC) group is 20 years old this year (2011). This brief review traces the origins of the group focussing on its more recent history and reviewing some of its major contributions to lupus research during the past two decades.
IsenbergDAGladmanD. The Systemic Lupus International Collaborating Clinics Group – origins and outcomes. Lupus2001; 10: 375–372.
2.
IsenbergDARamsey-GoldmanR. Systemic Lupus International Collaborating Clinic Group – onwards and upward. Lupus2006; 15: 606–607.
3.
GladmanDGinzlerEGoldsmithC. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum1996; 39: 363–369.
4.
UrowitzMBGladmanDIbanezD. Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Care Res2008; 59: 176–180.
5.
UrowitzMBGladmanDIbanezD. Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res2010; 62: 881–887.
6.
HanlyJUrowitzMBSanchez-GuerroJBaeSCGordonCWallaceDJ. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum2007; 56: 265–273.
7.
HanlyJGUrowitzMBSuL. Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrolment into an international inception cohort study. Arthritis Care Res2008; 59: 721–729.
8.
HanlyJUrowitzMBJacksonD. SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus. Ann Rheum Dis2011; 70: 961–967.
9.
HanlyJGUrowitzMBSuL. Prospective analysis of neuropsychiatric events in an international disease inception cohort of SLE patients. Ann Rheum Dis2010; 69: 529–535.
10.
HanlyJGUrowitzMBSiannisF. Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis. Arthritis Rheum2008; 58: 843–853.
11.
BernatskySBoivinJFJosephL. An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum2005; 52: 1481–1490.
12.
BernatskySJosephLBoivinJF. The relationship between cancer and medication exposures in systemic lupus erythematosus: a case cohort study. Ann Rheum Dis2008; 67: 74–79.
13.
WollestonSJFarewellVIsenbergDA. Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics Group (SLICC). J Rheumatol2004; 31: 2390–2394.
14.
IsenbergDAAllenEFarewellV. An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA. Am Rheum Dis2011; 70: 54–59.
15.
HochbergMC. Updating the American College of Rheumatology Revised Criteria for the Classification of Systemic Lupus Erythematosus (letter). Arthritis Rheum1997; 40: 1725–1725.
